U.S. Metals and Mining Stock News

Helios Technologies recently reported stronger-than-expected fourth-quarter 2025 non-GAAP earnings of US$0.81 per share with growth in both Electronics and Hydraulics segments, while also declaring a quarterly dividend of US$0.12 per share payable on April 27, 2026, to shareholders of record on April 13, 2026. Through its Balboa Water Group subsidiary, Helios is deepening its more-than-decade-long partnership with Jacuzzi Group by supplying advanced control, display, and multi-zone lighting...

U.S. Gold Corp. (NasdaqCM:USAU) released its Feasibility Study results for the fully permitted CK Gold Project in Wyoming. The study outlines project economics and highlights options such as mine expansion, longer mine life and additional revenue sources. The CK Gold Project is described as shovel ready, with all key permits in place. U.S. Gold, trading at $15.8, sits at a notable point in its development, with the CK Gold Project having cleared a major technical and regulatory hurdle. The...

Investors may be wondering whether Community Trust Bancorp at around US$61.58 still offers value, or if most of the upside is already reflected in the price. The stock has returned 2.4% over the last week, 0.1% over the past month, 9.2% year to date and 26.6% over the last year, with longer term returns of 86.2% over 3 years and 70.3% over 5 years. Recent coverage has focused on Community Trust Bancorp's position in the regional banking space and how investors are assessing its fundamentals...

Halliburton (NYSE:HAL) has agreed to acquire Sekal AS to expand its digital drilling automation capabilities. The deal brings Sekal’s DrillTronics technology into Halliburton’s LOGIX platform for global oilfield operations. The acquisition is intended to broaden HAL’s automation technology offering across its customer base. Halliburton is one of the largest global oilfield services providers, with a focus on drilling, completion, and production solutions for upstream energy companies. As...

Beyond Meat (BYND) has rounded out FY 2025 with fourth quarter revenue of US$61.6 million and basic EPS of US$0.84, capping a twelve month stretch where total revenue was US$275.5 million and basic EPS on a trailing basis came in at US$1.15. Over recent quarters, revenue has moved from US$76.7 million in Q4 2024 to US$61.6 million in Q4 2025, while quarterly EPS has shifted from a loss of US$0.65 in Q4 2024 to EPS of US$0.84 in Q4 2025. The story now turns to how durable these margins prove...

Q3 2026 headline results set the stage Nike (NKE) just posted Q3 2026 results with revenue of US$11.3b and basic EPS of US$0.35, putting fresh numbers on the table for investors tracking the story through a softer margin patch. Over recent quarters, revenue has moved in a tight band between US$11.1b and US$12.4b, while quarterly EPS has ranged from US$0.14 to US$0.78. This gives a clear view of how earnings have shifted around a relatively stable top line. With trailing twelve month EPS at...

In its latest earnings release, Acushnet Holdings reported a 7.2% year-on-year revenue increase that surpassed analyst expectations by 5.1%, but earnings per share fell short of forecasts. This combination of stronger-than-expected sales and weaker profitability highlights how Acushnet’s cost structure and margin trends are coming under closer investor scrutiny. Next, we’ll examine how Acushnet’s revenue beat but earnings miss could reshape its investment narrative and expectations for...

Occidental Petroleum recently enjoyed a multi-day run of gains that lifted its market value to about US$65.00 billion amid improving analyst sentiment. Behind the rally, a strong wave of upward earnings estimate revisions and a top-tier Zacks Rank #1 suggests analysts see meaningfully better profit prospects than before. Next, we’ll examine how this sharp upgrade in earnings expectations and sentiment could influence Occidental Petroleum’s existing investment narrative. Explore 25 top...

Wondering whether Denali Therapeutics at around US$19.68 is offering value or risk right now? This article breaks down what the current price could be telling you. The stock has pulled back with a 12.4% decline over the last 7 days and a 6.3% decline over 30 days. Yet year to date it is up 21.0% and 43.2% over the last year, which can shift how the market is thinking about its potential and risk profile. Recent coverage has focused on Denali Therapeutics as a high interest name in the...

Truist Securities recently reiterated its Hold rating on Pebblebrook Hotel Trust while citing improving fundamentals such as San Francisco’s recovery, easier 2026 comparisons, one-off events, and leverage reduction through asset sales, alongside a Q4 2025 earnings per share result that exceeded expectations despite softer revenue. At the same time, Pebblebrook went ex-dividend on March 31, 2026, reinforcing investor attention on income returns even as consensus analyst views remain broadly...

Kennedy-Wilson Holdings (KW) has drawn investor attention after recent trading left the real estate investment company with a market value of about US$1.5b and a last close near US$10.83 per share. See our latest analysis for Kennedy-Wilson Holdings. Recent trading leaves the 1-year total shareholder return at 32.93%. The 90-day share price return of 12% contrasts with weaker 3-year and 5-year total shareholder returns of 18.99% and 29.93% declines, and this may hint at improving momentum...

Event context and recent share performance Vertex (VERX) has been drawing investor attention after a period of weaker share performance, with the stock down about 16% over the past month and about 39% over the past 3 months. See our latest analysis for Vertex. Against a backdrop of weak longer term results, including a 1 year total shareholder return of about 67% in decline, the recent 7 day share price return of 3.69% at a share price of $12.09 hints that downside momentum may be easing...

Tarsus Pharmaceuticals (TARS) has drawn fresh attention after dosing the first participant in its Phase 2 Calliope trial of TP-05, an oral candidate aimed at preventing Lyme disease by killing infected ticks. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 progress and TP-03 milestone in China come as the share price sits at US$70.22, with a 7 day share price return of 4.9% but a 90 day share price return showing a 14.2% decline. The 1 year total shareholder return of...

If you are wondering whether Legend Biotech's share price reflects its underlying value, this article breaks down what the current market price may be implying about the company. The stock closed at US$19.05, with returns of 8.2% over the last week and 3.3% over the last month. The 1 year return stands at a 42.7% decline and the 3 year return at a 60.5% decline. Recent coverage around Legend Biotech has focused on its position in the biotech space and how investors are reassessing risk and...

If you are wondering whether Millrose Properties at US$28.51 still offers value after its recent run, this article will help you frame that question clearly. The stock has seen a 3.1% decline over the last 7 days and an 8.0% decline over the last 30 days, while still showing a 17.4% return over the last year and a 4.4% decline year to date. Recent news flow around Millrose Properties has focused on its position within the real estate sector and how sentiment toward property related names has...

KORE Group Holdings (KORE) reported Q3 FY 2025 revenue of US$68.7 million with a basic EPS loss of US$0.64, alongside trailing twelve month revenue of US$285.4 million and a TTM EPS loss of US$3.57, underscoring that the business is still operating in loss-making territory. Over recent quarters the company has seen revenue hold in a fairly tight band around the US$68 million to US$73 million range, while quarterly EPS losses have moved between roughly US$0.64 and US$1.31. The focus for...

Silver is sitting at the crossroads of several powerful forces. Demand tied to AI infrastructure, solar panels and electric vehicles is colliding with years of muted mine investment and flat output, all while energy costs and supply chain risks stay in focus due to ongoing global tensions. For investors looking for clear, focused exposure to this setup, a curated screener of top silver stocks can be a helpful filter that highlights miners with stronger balance sheets and lower production...

Conagra Brands (CAG) has followed up its latest quarter with mixed top and bottom line figures, reporting Q2 2026 revenue of US$2.98b and a basic EPS loss of US$1.39, alongside trailing 12 month revenue of US$11.23b and basic EPS of US$0.20. Over the past few reported quarters, revenue has moved from US$3.20b in Q2 2025 to US$2.84b in Q3 2025, US$2.78b in Q4 2025 and US$2.63b in Q1 2026, while basic EPS has shifted from US$0.60 to US$0.30, US$0.54 and US$0.34 respectively. This leaves...

Recently, Everus Construction Group reported earnings and revenue that exceeded analyst forecasts, alongside a record backlog in its specialized infrastructure and commercial construction services. This combination of stronger-than-expected operating results, a growing project pipeline, and increased institutional interest has sharpened investor focus on Everus’ role in data center, transmission, and distribution build-outs. With Everus’ record backlog underscoring robust demand, we’ll now...

MSC Industrial Direct (MSM) has put fresh numbers on the board for Q2 2026, with Q1 2026 revenue at US$965.7 million and basic EPS of US$0.93, set against a trailing twelve month EPS of US$3.67 on revenue of US$3.8 billion. Over recent quarters, revenue has ranged from US$891.7 million to US$978.2 million, while quarterly basic EPS has moved between US$0.70 and just over US$1.02. This gives investors a clear view of how earnings and sales have been tracking as margins come under pressure. See...

Taylor Devices (TAYD) just turned in its Q3 2026 scorecard, with recent quarterly figures showing revenue between about US$8.5 million and US$15.6 million over the past six reported quarters and EPS ranging from US$0.34 to US$1.17. Across that stretch, revenue moved from US$8.55 million in Q2 2025 to US$11.60 million in Q2 2026, while EPS shifted from US$0.34 to US$0.64, setting up a results season in which investors are paying close attention to how firmly margins are holding. See our full...

XCF Global (SAFX) closed FY 2025 with Q4 revenue of US$4.7 million and a basic EPS loss of US$0.09, alongside trailing twelve month EPS of US$0.52 on revenue of US$20.8 million that reflects the move into profitability over the past year. Over recent quarters the company has seen revenue shift from US$0 in Q1 2025 to US$6.6 million in Q2, US$9.6 million in Q3, then US$4.7 million in Q4. Quarterly EPS moved from a loss of US$0.05 in Q1 to a gain of US$0.83 in Q2 before returning to losses in...

Dave & Buster's Entertainment (PLAY) has just wrapped up FY 2026 with fourth quarter revenue of US$529.6 million and a basic EPS loss of US$1.15, as net income excluding extra items came in at a loss of US$39.8 million. Over the past year, quarterly revenue has moved between US$448.2 million and US$567.7 million, while basic EPS has ranged from a profit of US$0.63 in the first quarter to losses of around US$1.15 to US$1.22 in the back half of the year. This sets up a complex picture for...

Leadership change and what it could mean for Rush Enterprises stock Rush Enterprises (RUSH.A) has appointed long time executive Jody Pollard as Chief Operating Officer, replacing Jason Wilder. This shift places internal operational experience at the center of investor attention. See our latest analysis for Rush Enterprises. The leadership change comes as Rush Enterprises trades at US$66.02, with a 30 day share price return of an 8.76% decline, a 90 day share price return of 22.40% and a 5...